Researcher.Life Logo

BMC Medicine : Impact Factor & More

eISSN: 1741-7015pISSN: 1741-7015
JournalOpen Access

Aims and Scope of BMC Medicine

BMC Medicine is a peer-reviewed electronic-only medical journal published since 2003 by BioMed Central which is part of Springer Nature. It is described as "the flagship medical journal of the BMC series. An open access, open peer-reviewed general medical journal, BMC Medicine publishes outstanding and influential research in all areas of clinical practice, translational medicine, medical and health advances, public health, global health, policy, and general topics of interest to the biomedical and sociomedical professional communities". Less

Key Metrics

CiteScore
12.8
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.87 5-Year SI
SJR
Q1Medicine (all)
SNIP
3.18
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Medicine

BMC Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 3090 | USD 3790 | GBP 2690
Publication Time10
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2003
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 10
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Medicine

Bioresponsive engineered nanoparticles for immunomodulation.
  • 30 Oct 2025
  • BMC medicine
The nature and frequency of food and beverage marketing on Kenyan national television: a mixed-method analysis of food advertisements, parent and children's perspectives.
  • 30 Oct 2025
  • BMC medicine
The mediating role of biological age in the impact of mood instability symptoms on neurodegenerative disease and mortality.
  • 30 Oct 2025
  • BMC medicine
Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study.
  • 29 Oct 2025
  • BMC medicine
Cost-effectiveness of preventive treatment regimens for latent tuberculosis infection among key community-level populations.
  • 29 Oct 2025
  • BMC medicine
Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study
  • 28 Oct 2025
  • BMC Medicine
Bioresponsive engineered nanoparticles for immunomodulation.
  • 30 Oct 2025
  • BMC medicine
The nature and frequency of food and beverage marketing on Kenyan national television: a mixed-method analysis of food advertisements, parent and children's perspectives.
  • 30 Oct 2025
  • BMC medicine
The mediating role of biological age in the impact of mood instability symptoms on neurodegenerative disease and mortality.
  • 30 Oct 2025
  • BMC medicine
Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study.
  • 29 Oct 2025
  • BMC medicine
Cost-effectiveness of preventive treatment regimens for latent tuberculosis infection among key community-level populations.
  • 29 Oct 2025
  • BMC medicine
Concomitant use of direct oral anticoagulants and interacting antiarrhythmic drugs and the risk of stroke and bleeding among patients with non-valvular atrial fibrillation: a multinational cohort study
  • 28 Oct 2025
  • BMC Medicine

FAQs on BMC Medicine